Developer docs
API playgroundTry for free, no card

Search company profiles

Helioscopie

Full company profile

uuid002z5dn

Namestring
Helioscopie
Legal namestring
Helioscopie
Websiteurl
helioscopie.fr
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Helioscopie S.A. is a France-based, privately held medical device manufacturer founded in 2000 and headquartered in Vienne, Isère. The company designs, manufactures, and commercializes implantable medical devices (EU MDR Class I to III, CE marked under EN ISO 13485) with a core specialization in the surgical and endoscopic treatment of obesity. Its proprietary portfolio comprises the Heliosphere air-filled intragastric balloon (marketed in two volumes for one- or two-phase treatment), the Heliogast adjustable gastric band family (HAGA and HAGE variants), and the Heliosond gastric calibration probe used in bariatric surgery. Helioscopie manufactures 100% of its Heliogast line and the broader proprietary range in controlled-atmosphere zones at the Vienna facility, covering silicone molding, metal/silicone/polymer assembly, blister packaging, and steam sterilization.

Beyond proprietary manufacturing, Helioscopie holds exclusive French distribution rights for two complementary franchises: Dynamesh PVDF hernia repair implants (distributed from a German producer) and Bulkamid polyacrylamide hydrogel for female stress urinary incontinence (from Contura). This layered model lets the firm monetize internal R&D and manufacturing on obesity devices while extending commercial reach into parietal and uro-gynecological surgery through distribution partnerships.

Helioscopie commercializes through a direct national sales force targeting digestive, bariatric, uro-gynecological surgeons, and gastroenterologists across France, supplemented by a distributor network covering 35+ countries internationally. Marketing relies on specialty congress participation (e.g., MEDICA, EHS, CFU), clinical data publications, and surgical training via the Listo Academy webinar program. With over 1,500 practitioners using its devices and 25+ years of operating history, the company positions itself as a specialist mid-size European player in niche implantable obesity and adjacent surgical specialties.

Short descriptiontext

Helioscopie is a privately held French medical device manufacturer (founded 2000, Vienne, Isère) that designs, makes, and distributes Class I–III CE-marked implants for bariatric surgery (Heliosphere, Heliogast, Heliosond) and exclusively distributes Dynamesh hernia mesh and Bulkamid urinary incontinence products in France and 35+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLyon, France
HQ citystring
Lyon
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bariatric medical devices, intragastric balloon systems, adjustable gastric bands, hernia repair implants, urinary incontinence treatments
Industry3 codes
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAEAC
Advanced Endoscopy (ERCP/EUS/Interventional)
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Bariatric Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Manufacturing and Sales
TypeHardware Sales
Description

Helioscopie designs, manufactures, and commercializes implantable medical devices Class I to III, specialized in surgical or endoscopic treatment of obesity. The company also distributes exclusive brands Bulkamid and Dynamesh for the French market. Products are sold through a direct commercial network in France and via international distributors. Manufacturing is performed in-house at the Vienna facility with controlled-atmosphere production zones.

helioscopie.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1HELIOSPHERE
Description

Air-filled intragastric balloon for non-surgical treatment of obesity.

helioscopie.fr
+2 more records
Core offering1 text field

Helioscopie designs, manufactures, and commercializes implantable medical devices (Class I to III) for the surgical and endoscopic treatment of obesity, including the proprietary Heliosphere air-filled intragastric balloon, Heliogast adjustable gastric band, and Heliosond gastric calibration probe, all produced at its Vienna, France facility. The company also serves as the exclusive French distributor for two third-party brands: Dynamesh PVDF-based hernia repair implants and Bulkamid urethral filling agent for stress urinary incontinence.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 68% excess weight loss after 5 years of treatment with Heliogast HAGA adjustable gastric band
+4 more records
Product overview1 text field

Helioscopie is a French medical device manufacturer specializing in obesity treatment and related surgical solutions. The product portfolio consists of proprietary devices (HELIOSPHERE air-filled intragastric balloon, HELIOGAST adjustable gastric band, HELIOSOND gastric calibration probe) and distributed products (DynaMesh® PVDF wall reinforcement implants for hernia repair, BULKAMID® urethral filling agent for urinary incontinence). The company designs, manufactures, and commercializes implantable medical devices Class I to III, with specialization in minimally invasive and reversible surgical/endoscopic obesity treatments, wall reinforcement (parietal surgery), and urinary incontinence solutions.

Product and service5 records
1HELIOSPHERE intragastric balloon
CategoryBariatric medical devices - intragastric balloons
Description

Air-filled intragastric balloon weighing under 15 grams, implanted endoscopically to occupy volume in the stomach and induce satiety for non-surgical obesity treatment over a maximum 6-month implantation period. Designed to limit nausea and vomiting by avoiding pressure on gastric mucosae through free positioning.

2HELIOGAST adjustable gastric band (HAGA and HAGE)
CategoryBariatric medical devices - adjustable gastric bands
Description

Adjustable minimally invasive silicone gastric band implanted around the upper part of the stomach to divide it like an hourglass and induce satiety. Connected via catheter to a subcutaneous implantable chamber that allows post-operative adjustment of the internal diameter through saline injection. HAGA features a unique 'double support' adjustable membrane for enhanced band stability.

3HELIOSOND gastric calibration probe
CategoryBariatric surgical accessories
Description

Sterile single-use silicone calibration probe with atraumatic soft conical tip and optional inflatable balloon (up to 40 cm³), used in bariatric surgery including sleeve gastrectomy, bypass, and gastric band placement. Available in 36Fr or 39Fr sizes with biocompatible silicone construction.

4DynaMesh PVDF wall reinforcement implants
CategoryHernia repair implants (distributed)
Description

Polyvinylidene fluoride (PVDF) wall reinforcement implants for inguinal hernia (Lichtenstein, TEP, TAPP), ventral hernia/evisceration (IPOM, CICAT), umbilical hernia, peristomal hernia, and hiatal hernia repair. Backed by over 20 years of clinical studies demonstrating biocompatibility, stability, and resistance to aging.

5BULKAMID urethral filling agent
CategoryUro-gynecology injectables (distributed)
Description

Urethral bulking agent composed of 97.5% water and 2.5% polyacrylamide, injected into urethral tissues to add volume and coapt the urethra for minimally invasive, non-incisional treatment of female stress urinary incontinence. Clinical data shows efficacy lasting several years, with effectiveness reported up to 7 years post-treatment.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Helioscopie is the exclusive French distributor for Dynamesh brand of PVDF wall reinforcement implants. Dynamesh is the only hernia mesh made from polyvinylidene fluoride (PVDF), offering products for inguinal hernia, ventral hernia, umbilical hernia, peristomal hernia, and hiatal hernia repair. Products are CE certified under EU MDR 2017/745 (TÜV SÜD - 0123). Helioscopie promotes Dynamesh at major hernia surgery congresses including Hernia-France, EHS, and Colorectal Day.

2Bulkamid (manufactured by Contura)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Helioscopie is the exclusive French distributor for Bulkamid, a urethral filling agent composed of 97.5% water and 2.5% polyacrylamide used to treat female stress urinary incontinence. More than 70,000 women have been treated with Bulkamid in 25 countries over 15 years. Helioscopie promotes Bulkamid at urology and uro-gynecology congresses including CFU (Congrès Français d'Urologie), SIFUD-PP, SCGP, and the Santé Rennes congress.

helioscopie.fr
3Listo Academy
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Helioscopie partners with Listo Academy to organize surgical training webinars and masterclasses featuring live demonstrations using Helioscopie-distributed implants (particularly Dynamesh). Sessions are led by international surgeons (Dr. Khalil, Pr. Moszkowicz, Dr. Zarras, Dr. Perrin) and have reached participants from France, Saudi Arabia, Algeria, Egypt, Oman, Syria, India, and Mauritius. The partnership combines theoretical presentations, live surgery, and interactive exchanges.

helioscopie.fr
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Helioscopie

Bariatric Medical Deviceshelioscopie.fr

Helioscopie is a privately held French medical device manufacturer (founded 2000, Vienne, Isère) that designs, makes, and distributes Class I–III CE-marked implants for bariatric surgery (Heliosphere, Heliogast, Heliosond) and exclusively distributes Dynamesh hernia mesh and Bulkamid urinary incontinence products in France and 35+ countries.

What Helioscopie does

Helioscopie S.A. is a France-based, privately held medical device manufacturer founded in 2000 and headquartered in Vienne, Isère. The company designs, manufactures, and commercializes implantable medical devices (EU MDR Class I to III, CE marked under EN ISO 13485) with a core specialization in the surgical and endoscopic treatment of obesity. Its proprietary portfolio comprises the Heliosphere air-filled intragastric balloon (marketed in two volumes for one- or two-phase treatment), the Heliogast adjustable gastric band family (HAGA and HAGE variants), and the Heliosond gastric calibration probe used in bariatric surgery. Helioscopie manufactures 100% of its Heliogast line and the broader proprietary range in controlled-atmosphere zones at the Vienna facility, covering silicone molding, metal/silicone/polymer assembly, blister packaging, and steam sterilization.

Beyond proprietary manufacturing, Helioscopie holds exclusive French distribution rights for two complementary franchises: Dynamesh PVDF hernia repair implants (distributed from a German producer) and Bulkamid polyacrylamide hydrogel for female stress urinary incontinence (from Contura). This layered model lets the firm monetize internal R&D and manufacturing on obesity devices while extending commercial reach into parietal and uro-gynecological surgery through distribution partnerships.

Helioscopie commercializes through a direct national sales force targeting digestive, bariatric, uro-gynecological surgeons, and gastroenterologists across France, supplemented by a distributor network covering 35+ countries internationally. Marketing relies on specialty congress participation (e.g., MEDICA, EHS, CFU), clinical data publications, and surgical training via the Listo Academy webinar program. With over 1,500 practitioners using its devices and 25+ years of operating history, the company positions itself as a specialist mid-size European player in niche implantable obesity and adjacent surgical specialties.

Helioscopie firmographics

Firmographics
Name
Helioscopie
Legal name
Helioscopie
Website
https://helioscopie.fr
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Helioscopie is a privately held French medical device manufacturer (founded 2000, Vienne, Isère) that designs, makes, and distributes Class I–III CE-marked implants for bariatric surgery (Heliosphere, Heliogast, Heliosond) and exclusively distributes Dynamesh hernia mesh and Bulkamid urinary incontinence products in France and 35+ countries.
Ownership category
akta.pro rank

Helioscopie industry classification

Industry
Product category
Bariatric Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAEAC
Advanced Endoscopy (ERCP/EUS/Interventional)
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)

Keywords

  • Bariatric medical devices
  • Intragastric balloon systems
  • Adjustable gastric bands
  • Hernia repair implants
  • Urinary incontinence treatments

Where Helioscopie is headquartered

Location

Headquarters

HQ city
Lyon
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Helioscopie business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Manufacturing and Sales: Helioscopie designs, manufactures, and commercializes implantable medical devices Class I to III, specialized in surgical or endoscopic treatment of obesity. The company also distributes exclusive brands Bulkamid and Dynamesh for the French market. Products are sold through a direct commercial network in France and via international distributors. Manufacturing is performed in-house at the Vienna facility with controlled-atmosphere production zones.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Helioscopie product offering

Product offering

Core offering

Helioscopie designs, manufactures, and commercializes implantable medical devices (Class I to III) for the surgical and endoscopic treatment of obesity, including the proprietary Heliosphere air-filled intragastric balloon, Heliogast adjustable gastric band, and Heliosond gastric calibration probe, all produced at its Vienna, France facility. The company also serves as the exclusive French distributor for two third-party brands: Dynamesh PVDF-based hernia repair implants and Bulkamid urethral filling agent for stress urinary incontinence.

Product overview

Helioscopie is a French medical device manufacturer specializing in obesity treatment and related surgical solutions. The product portfolio consists of proprietary devices (HELIOSPHERE air-filled intragastric balloon, HELIOGAST adjustable gastric band, HELIOSOND gastric calibration probe) and distributed products (DynaMesh® PVDF wall reinforcement implants for hernia repair, BULKAMID® urethral filling agent for urinary incontinence). The company designs, manufactures, and commercializes implantable medical devices Class I to III, with specialization in minimally invasive and reversible surgical/endoscopic obesity treatments, wall reinforcement (parietal surgery), and urinary incontinence solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • HELIOSPHERE: Air-filled intragastric balloon for non-surgical treatment of obesity.
  • HELIOGAST
  • HELIOSOND

Products and services

  • HELIOSPHERE intragastric balloon Air-filled intragastric balloon weighing under 15 grams, implanted endoscopically to occupy volume in the stomach and induce satiety for non-surgical obesity treatment over a maximum 6-month implantation period. Designed to limit nausea and vomiting by avoiding pressure on gastric mucosae through free positioning.
  • HELIOGAST adjustable gastric band (HAGA and HAGE) Adjustable minimally invasive silicone gastric band implanted around the upper part of the stomach to divide it like an hourglass and induce satiety. Connected via catheter to a subcutaneous implantable chamber that allows post-operative adjustment of the internal diameter through saline injection. HAGA features a unique 'double support' adjustable membrane for enhanced band stability.
  • HELIOSOND gastric calibration probe Sterile single-use silicone calibration probe with atraumatic soft conical tip and optional inflatable balloon (up to 40 cm³), used in bariatric surgery including sleeve gastrectomy, bypass, and gastric band placement. Available in 36Fr or 39Fr sizes with biocompatible silicone construction.
  • DynaMesh PVDF wall reinforcement implants Polyvinylidene fluoride (PVDF) wall reinforcement implants for inguinal hernia (Lichtenstein, TEP, TAPP), ventral hernia/evisceration (IPOM, CICAT), umbilical hernia, peristomal hernia, and hiatal hernia repair. Backed by over 20 years of clinical studies demonstrating biocompatibility, stability, and resistance to aging.
  • BULKAMID urethral filling agent Urethral bulking agent composed of 97.5% water and 2.5% polyacrylamide, injected into urethral tissues to add volume and coapt the urethra for minimally invasive, non-incisional treatment of female stress urinary incontinence. Clinical data shows efficacy lasting several years, with effectiveness reported up to 7 years post-treatment.

Quantifiable outcome

  • 68% excess weight loss after 5 years of treatment with Heliogast HAGA adjustable gastric band
  • +4 more outcomes

Companies that use Helioscopie

Customer profile

Named customers16 records

Segments3 records

Ideal customer profiles2 records

Helioscopie technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Helioscopie partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • DynaMesh (manufactured by German producer)coreChannel Partner/ Reseller/ DistributorHelioscopie is the exclusive French distributor for Dynamesh brand of PVDF wall reinforcement implants. Dynamesh is the only hernia mesh made from polyvinylidene fluoride (PVDF), offering products for inguinal hernia, ventral hernia, umbilical hernia, peristomal hernia, and hiatal hernia repair. Products are CE certified under EU MDR 2017/745 (TÜV SÜD - 0123). Helioscopie promotes Dynamesh at major hernia surgery congresses including Hernia-France, EHS, and Colorectal Day.
  • Bulkamid (manufactured by Contura)coreChannel Partner/ Reseller/ DistributorHelioscopie is the exclusive French distributor for Bulkamid, a urethral filling agent composed of 97.5% water and 2.5% polyacrylamide used to treat female stress urinary incontinence. More than 70,000 women have been treated with Bulkamid in 25 countries over 15 years. Helioscopie promotes Bulkamid at urology and uro-gynecology congresses including CFU (Congrès Français d'Urologie), SIFUD-PP, SCGP, and the Santé Rennes congress.
  • Listo AcademyminorStrategic or Co-development PartnerHelioscopie partners with Listo Academy to organize surgical training webinars and masterclasses featuring live demonstrations using Helioscopie-distributed implants (particularly Dynamesh). Sessions are led by international surgeons (Dr. Khalil, Pr. Moszkowicz, Dr. Zarras, Dr. Perrin) and have reached participants from France, Saudi Arabia, Algeria, Egypt, Oman, Syria, India, and Mauritius. The partnership combines theoretical presentations, live surgery, and interactive exchanges.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Helioscopie competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Helioscopie social profiles

Digital presence

Helioscopie compliance and trust

Trust signal

Compliance5 records

Helioscopie financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Helioscopie leadership team

Management profile

Number of profiles

Profiles1 record

Helioscopie funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Helioscopie M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Helioscopie

What does Helioscopie do?

Helioscopie designs, manufactures, and commercializes implantable medical devices (Class I to III) for the surgical and endoscopic treatment of obesity, including the proprietary Heliosphere air-filled intragastric balloon, Heliogast adjustable gastric band, and Heliosond gastric calibration probe, all produced at its Vienna, France facility. The company also serves as the exclusive French distributor for two third-party brands: Dynamesh PVDF-based hernia repair implants and Bulkamid urethral filling agent for stress urinary incontinence.

Is Helioscopie a public or private company?

Helioscopie is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Helioscopie founded?

Helioscopie was founded in 2000. It employs 11 to 50 people.

Where is Helioscopie based?

Helioscopie is headquartered in Lyon, France, in the Europe region.

How does Helioscopie make money?

One revenue line is on record: medical Device Manufacturing and Sales.

Does Helioscopie have an API?

No public API is recorded for Helioscopie.

What industry is Helioscopie in?

Helioscopie's product category is Bariatric Medical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAKAEAC, Advanced Endoscopy (ERCP/EUS/Interventional). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlobal Intragastric Balloons Market 2018-2022 - Key Vendors are Allurion Technologies, Apollo Endosurgery, Helioscopie, Obalon Therapeutics, ReShape Lifesciences & Spatz FGIAResearchAndMarkets added a report on the global intragastric balloons market, projecting a CAGR of 25.18% from 2018 to 2022. The report cites cost-effectiveness and safety as drivers, while complications like perforation and deflation are challenges. Key vendors include Allurion Technologies, Apollo Endosurgery, and Obalon Therapeutics.PR NewswireGlobal Gastric Band Devices Market 2017-2021Technavio released its 2017-2021 market forecast for the global gastric band devices market, projecting a compound annual growth rate (CAGR) of 3.74% driven by rising obesity awareness and advances in minimally invasive surgical procedures. The report identifies market growth constraints including complications associated with gastric bands, lack of reimbursement, and medical professionals' preference for alternative bariatric procedures. Key vendors operating in this market include Apollo Endosurgery, COUSIN BIOTECH, Ethicon, Helioscopie, Millennium Surgical, and MID (Médical Innovation Développement).PR NewswireGlobal Gastric Band Devices Market 2017-2021: Key Vendors are Apollo Endosurgery, Cousin Biotech, Ethicon, Helioscopie, Millennium Surgical & MIDThe global gastric band devices market is projected to grow at a CAGR of 3.74% from 2017 to 2021. Key vendors include Apollo Endosurgery, Cousin Biotech, Ethicon, Helioscopie, Millennium Surgical, and MID. Growth is driven by laparoscopic procedures, though high cost and lack of reimbursement remain barriers.